CEBP http://www.cancermicroenvironment.tau.ac.il/welcome2009.html Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunker, C. H.
Right arrow Articles by Kuller, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunker, C. H.
Right arrow Articles by Kuller, L. H.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 726-729, August 2002
© 2002 American Association for Cancer Research

High Prevalence of Screening-detected Prostate Cancer among Afro-Caribbeans

The Tobago Prostate Cancer Survey1

Clareann H. Bunker2, Alan L. Patrick, Badrinath R. Konety3, Rajiv Dhir, Adam M. Brufsky, Carlos A. Vivas, Michael J. Becich, Donald L. Trump and Lewis H. Kuller

Departments of Epidemiology [C. H. B., A. L. P., L. H. K.], Medicine [A. M. B., D. L. T.], Urology [B. R. K., C. A. V.], and Pathology [R. D., M. J. B.], University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Department of Medicine, Tobago Regional Hospital, Scarborough, Tobago, Trinidad & Tobago [A. L. P.]; and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15260 [R. D., A. M. B., M. J. B., D. L. T., L. H. K.]

Risk for prostate cancer is high among African Americans.We hypothesized that risk for prostate cancer isalso high in other populations of African descent. Our objective was to determine the screening-detected prevalence of prostate cancer in the predominantly Afro-Caribbean population on the island of Tobago. Male residents, ages 40–79 years, were invited to participate in a population-based screening for prostate cancer using serum prostate-specific antigen (PSA) and digital rectal exam (DRE). Men with elevated PSA (>=4 ng/ml) or abnormal DRE were offered an ultrasound-guided sextant biopsy of the prostate gland. Men (2484), ages 40–79 years, underwent prostate cancer screening between September 1997 and June 2001. Mean age was 55.9, SD was 10.6 years, and median was 54 years. Mean serum PSA was 14.8 ng/ml, SD was 376 [excluding 4 values >= 2 SD above the mean (1,112, 1,317, 1,818, and 18,330 ng/ml) mean PSA was 5.5 ng/ml and SD was 29.6], and median PSA was 1.2 ng/ml. Elevated PSA and/or abnormal DRE were observed in 31% (759 of 2484) overall, and in age groups 40–49 (87 of 843, 10%), 50–59 (201 of 729, 28%), 60–69 (262 of 584, 45%), and 70–79 (209 of 328, 64%). Of 681 men biopsied, 259 (38%, or 10% of the 2484 screened) were diagnosed with prostate cancer. Age-specific rates of screening detected prostate cancer were: 1%, ages 40–79 years; 7%, ages 50–59 years; 18%, ages 60–69 years; and 28%, ages 70–79 years. These screening results indicate a very high screening-detected prevalence of prostate cancer in this population of West African descent. These data support the hypothesis that populations of African descent share genetic and/or lifestyle factors that contribute to their elevated risk for prostate cancer.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. S. Consedine, B. A. Adjei, P. M. Ramirez, and J. M. McKiernan
An Object Lesson: Source Determines the Relations That Trait Anxiety, Prostate Cancer Worry, and Screening Fear Hold with Prostate Screening Frequency
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1631 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. J. Prior, S. M. Roth, X. Wang, C. Kammerer, I. Miljkovic-Gacic, C. H. Bunker, V. W. Wheeler, A. L. Patrick, and J. M. Zmuda
Genetic and environmental influences on skeletal muscle phenotypes as a function of age and sex in large, multigenerational families of African heritage
J Appl Physiol, October 1, 2007; 103(4): 1121 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am J Mens HealthHome page
N. S. Consedine, D. Horton, T. Ungar, A. K. Joe, P. Ramirez, and L. Borrell
Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men
American Journal of Men's Health, March 1, 2007; 1(1): 29 - 43.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. L. Freedman, C. A. Haiman, N. Patterson, G. J. McDonald, A. Tandon, A. Waliszewska, K. Penney, R. G. Steen, K. Ardlie, E. M. John, et al.
From the Cover: Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
PNAS, September 19, 2006; 103(38): 14068 - 14073.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. S. Consedine, A. H. Morgenstern, E. Kudadjie-Gyamfi, C. Magai, and A. I. Neugut
Prostate cancer screening behavior in men from seven ethnic groups: the fear factor.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 228 - 237.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.